Is a complete FRA/GE9 research report available?

No complete published report is available for fra/GE9 (FRA/GE9) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/GE9 (FRA/GE9)

Frankfurt Stock Exchange: FRA/GE9 · EUR

€286

-1.30 (-0.5%)· Recorded snapshot

Market cap	17.3B
Revenue (ttm)	3.6B
Net income (ttm)	689.7M
EPS (ttm)	€11.1
P/E (trailing)	25.1x
P/E (forward)	20.1x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.6B
Net income (ttm): 689.7M
EPS (ttm): €11.1
P/E (trailing): 25.1x
P/E (forward): 20.1x
Market cap: 17.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-08 02:00 UTC

All FRA/GE9 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DE
Employees	3,119
Employees Change	480%
Employees Change Percent	18.19
Enterprise value	EUR 20.6B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	DK0010272202
Last refreshed	2026-09-08
Market cap	EUR 17.3B
Price	EUR 286
Price currency	EUR
Rev Per Employee	1,159,302.44x
Sector	Healthcare
Sector PE	38.03
Sector PE Fwd	14.34
Sic	2836
Symbol	fra/GE9
Website	https://www.genmab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.99%
EV Earnings	29.84x
EV/EBIT	17.63x
EV/EBITDA	16.87x
EV/FCF	27.06x
EV/Sales	5.69x
FCF yield	4.4%
Forward P/E	20.12x
P/B ratio	3.32x
P/E ratio	25.07x
P/S ratio	4.78x
PE Ratio10 Y	41.3x
PE Ratio3 Y	20.4x
PE Ratio5 Y	30.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.29%
EBITDA Margin	33.33%
FCF margin	21.39%
Gross margin	93.03%
Gross Profit	EUR 3.4B
Gross Profit Growth	20.39%
Gross Profit Growth Q	23.39%
Gross Profit Growth3 Y	17.39%
Gross Profit Growth5 Y	26.91%
Net Income	EUR 689.7M
Net Income Growth	-37.9%
Net Income Growth Q	-9.82%
Net Income Growth Qo Q	471.7%
Net Income Growth Years	0%
Net Income Growth3 Y	5.02%
Net Income Growth5 Y	14.48%
Pretax Margin	21.93%
Profit Margin	19.08%
Profit Per Employee	EUR 221,140
Profitable Quarters	EUR 35
Profitable Years	13
ROA	8.79
Roa5y	10.27
ROCE	11.73
ROE	14
Roe5y	18.28
ROIC	12.07
Roic5y	66.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.39%
Cagr15y	31.06%
Cagr1y	36.01%
Cagr20y	12.21%
Cagr3y	-6.33%
Cagr5y	-6.92%
EPS Growth	-36.79
EPS Growth Q	-9.41
EPS Growth Qo Q	491.6
EPS Growth Years	0
EPS Growth3 Y	7.05
EPS Growth5 Y	15.83
FCF Growth	-12.75%
FCF Growth Q	-5.77%
FCF Growth3 Y	1.65%
FCF Growth5 Y	-0.57%
OCF Growth	-14.08%
OCF Growth Q	-17.74%
OCF Growth Qo Q	1,600%
OCF Growth10 Y	26.01%
OCF Growth3 Y	0.23%
OCF Growth5 Y	-0.81%
Revenue Growth	22.26x
Revenue Growth Q	24.87x
Revenue Growth Qo Q	28.91x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	20.2x
Revenue Growth5 Y	28.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.44
Assets	EUR 11B
Cash	EUR 1.3B
Current Assets	EUR 2.4B
Current Liabilities	EUR 981.5M
Debt	EUR 4.6B
Debt EBITDA	EUR 3.78
Debt Equity	EUR 0.89
Debt FCF	EUR 6.07
Equity	EUR 5.2B
Interest Coverage	4.96
Liabilities	EUR 5.7B
Long Term Assets	EUR 8.5B
Long Term Liabilities	EUR 4.8B
Net Cash	EUR -3.3B
Net Cash By Market Cap	EUR -19.05
Net Debt EBITDA	EUR 2.73
Net Debt Equity	EUR 0.63
Net Debt FCF	EUR 4.33
Tangible Book Value	EUR -2.9B
Tangible Book Value Per Share	EUR -47.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.46
Inventory Turnover	18.58
Net Working Capital	EUR 405.3M
Quick ratio	2.44
Working Capital	EUR 1.5B
Working Capital Turnover	EUR 1.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	103.97%
1Y total return	35.98%
200-day SMA	249.4
3Y total return	-17.81%
50-day SMA	262.4
50-day SMA vs 200-day SMA	50over200
5Y total return	-30.11%
All Time High	445.1
All Time High Change	-35.39%
All Time High Date	2022-12-05
All Time Low	3.1
All Time Low Change	9,177.42%
All Time Low Date	2002-11-27
ATR	4.45
Ch YTD	6.8
High	286.3
High52	303.8
High52 Date	2026-01-15
High52ch	-5.76%
Low	286.3
Low52	202.8
Low52 Date	2026-06-03
Low52ch	41.17%
Ma50ch	9.62%
Price vs 200-day SMA	15.31%
RSI	60.94
RSI Monthly	60.21
RSI Weekly	69.09
Sharpe ratio	1.36x
Sharpe Ratio3y	-0.16x
Sharpe Ratio5y	0x
Sortino ratio	2.3
Sortino Ratio3y	-0.07
Sortino Ratio5y	0.17
Total Return	1.73%
Tr YTD	6.8
Tr15y	5,679.74%
Tr1m	14.99%
Tr1w	1.09%
Tr3m	41.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58,960,720%
Net Borrowing	4,613,863,204
Shares Insiders	1.22%
Shares Institutions	63.33%
Shares Qo Q	-3.36%
Shares Yo Y	-1.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 624.1M
Adjusted OCF	643,345,500
Average Volume	7.9x
Bv Per Share	87.34
CAPEX	EUR -19.3M
Ch10y	104
Ch15y	5,679.7
Ch1m	14.99
Ch1w	1.09
Ch1y	35.98
Ch20y	901
Ch3m	41.33
Ch3y	-17.81
Ch5y	-30.11
Ch6m	22.28
Change	-0.45%
Change From Open	0
Close	287.6
Days Gap	-0.45
Depreciation Amortization	37,021,108
Earnings Date	2026-11-05
EBIT	EUR 1.2B
EBITDA	EUR 1.2B
EPS	EUR 11.07
F Score	4
FCF	EUR 760.6M
FCF EV Yield	3.7x
Financing CF	4,337,986,800
Fiscal Year End	December
Founded	1,998
Goodwill	305,639,380
Graham Number	149.62551
Graham Upside	-47.97
Income Tax	EUR 103.3M
Investing CF	-4,930,564,900
Is Primary Listing	0
Last Earnings Date	2026-08-06
Last Report Date	2026-06-30
Lynch Fair Value	EUR 166
Lynch Upside	-42.23
Ma150	241.6
Ma150ch	19.02%
Ma20	282
Ma20ch	2%
Net CF	181,187,100
Next Earnings Date	2026-11-05
Open	286.3
P FCF Ratio	22.73
P FCF Ratio SBC	27.71
P OCF Ratio	22.17
P OCF Ratio SBC	26.88
Ppne	218,682,824
Price Date	2026-09-07
Price EBITDA	EUR 14.35
Relative Volume	0.36x
Revenue	3,615,864,300x
SBC By Revenue	3.78x
Share Based Comp	136,546,800
Tax By Revenue	2.86x
Tax Rate	13.02%
Tr20y	901.04%
Tr6m	22.28%
Z Score	2.91

FRA/GE9 (FRA/GE9)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/GE9

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All FRA/GE9 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on FRA/GE9

Frequently asked questions